GenturaDx
Hayward
About GenturaDx
Molecular diagnostic company focused on making multiplexed molecular testing both affordable and practical for any laboratory to perform. The company’s IDbox™ system and single-use cassette will circumvent long-standing barriers of costs, automation and performance facilitating in-house lab testing for actionable results. In July 2012, GenturaDx was acquired by Luminex Corp. (NASDAQ:LMNX).
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $21.0M
- Funding stage: M&A
- Last round: Series C (Jan 2008)
- Website: genturadx.com
- Phone: +1 (510) 725-4767
Industries & Categories
Biopharma, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/genturadx-2770374 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.